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RevHuman immunodeﬁciency virus type 1 (HIV-1) needs to overcome cellular counter mechanisms such as to
successfully propagate itself. Results of our recent studies show that overexpression of insulin-like growth
factor II mRNA binding protein 1 (IMP1) inhibits production of infectious HIV-1 particles through adversely
affecting virus maturation. Here, we report that IMP1 interacts with HIV-1 Rev protein and its ectopic
expression causes relocation of Rev from the nucleus to the cytoplasm. In accordance with this observation,
ectopic expression of IMP1 severely diminishes Rev-dependent expression of CAT enzyme and disturbs HIV-1
RNA expression by causing accumulation of the multiple spliced viral RNA. Results of mutagenesis analysis
further reveal that the KH4 domain represents the key element of IMP1 in modulating HIV-1 RNA expression.
Taken together, these data suggest, in addition to hampering virus assembly, that IMP1 also has an effect on
Rev-dependent viral RNA expression.
© 2009 Elsevier Inc. All rights reserved.Introduction
Human immunodeﬁciency virus type 1 (HIV-1) encodes nine
genes including three structural genes (gag, pol and env), two
regulatory genes (tat and rev) and four accessory genes (vpr, vif, vpu
and nef; Frankel and Young, 1998). HIV-1 life cycle falls into two
phases. The early phase starts from virus entry and ﬁnishes till
integration of viral cDNA into the host chromosomal DNA to form a
provirus. The late phase begins with transcription of HIV-1 RNA and
ends with generation of infectious virus particles. HIV-1 replicates
strictly within cells by exploiting various cellular pathways and
consuming cellular resources (Goff, 2007). This is well reﬂected by the
fact that HIV-1 relies on the cellular RNA polymerase II to produce and
amplify viral RNA genome as well as on the cellular translation
machinery to make viral proteins. Furthermore, although HIV-1 Gag
protein is capable of generating virus-like particles, in order to
successfully check out of the cells, these Gag particles need to hijack
the ESCRT (endosomal sorting complex required for transport) for
budding and release (Fujii et al., 2007). To defend itself from HIV-1
infection, cells have evolved various means to target and block
different steps of HIV-1 replication (Goff, 2007), which is well
manifested by several recently discovered HIV-1 restriction factors.
IMP1 is one of the zip-code binding proteins (ZBPs) that recognize
cis-acting RNA elements and regulate the activity of mRNA targetavis Institute-Jewish General
bec, Canada H3T 1E2. Fax: +1
ll rights reserved.(Jambhekar and Derisi, 2007). IMP1 and its homologues from
different species form a small protein family named the VICKZ family,
including IMP1, IMP2 and IMP3 in human, coding region determinant-
binding protein (CRD-BP) in mouse, ZBP1 in chicken, and Vg1-RBP/
Vera in Xenopus (Yisraeli, 2005). The VICKZ family members all
possess two RNA recognition motifs (RRMs) followed by four tandem
hnRNP K homology (KH) domains. IMP1 was originally discovered
through its association with the leader 3 of the insulin-like growth
factor II (IGF II) mRNA and is known for its ability to regulate the
expression of IGF II at the early stage of mouse embryonic
development (Nielsen et al., 1999). A few more RNA targets of IMP1
were subsequently identiﬁed such as H19 RNA (Runge et al., 2000),
tau mRNA (Atlas et al., 2004), c-myc mRNA (Doyle et al., 1998) and
PABP mRNA (Patel and Bag, 2006). A comprehensive microarray
analysis of RNA composition of IMP1-containing RNP granules
suggests that IMP1 potentially controls the activity of 2–3% of the
cellular transcriptome (Jonson et al., 2007). The importance of IMP1 in
cell life is further highlighted by the ﬁndings that the KH4-deleted
IMP1 mutant acts in a dominant-negative fashion to inhibit cell
migration (Natkunam et al., 2007) and that elevated expression of
IMP1 is associated with several types of cancers such as colorectal
carcinoma (Ross et al., 2001), brain tumors (Ioannidis et al., 2004),
non-small cell lung carcinoma (Ioannidis et al., 2004), and mesen-
chymal tumors (Ioannidis et al., 2001).
Given that IMP1 is a typical RNA-binding protein and that its
intrinsic function is to regulate the activity of its RNA target (Yisraeli,
2005), we speculated that IMP1 may also modulate HIV-1 RNA
expression. Indeed, results of this study revealed that ectopic
expression of IMP1 caused signiﬁcant accumulation of the multiple
Fig. 1. Ectopic expression of FLAG-IMP1 alters subcellular localization of Rev protein.
(A) Domain structure of IMP1 and its mutants. Positions of the deleted amino acids are
denoted. (B) IMP1 interacts with Rev. HEK293T cells were co-transfected with the Rev
DNA and the wild-type FLAG-IMP1 or the mutated FLAG-ΔRRM(1–2), FLAG-ΔKH(1–4)
and FLAG-ΔKH(3–4) DNA. Cell lysates were incubated with agarose beads coated with
anti-FLAG antibody to immunoprecipitate FLAG-IMP1 protein and its mutants. The
precipitated materials were assessed by Western blotting using either anti-FLAG or
anti-Rev antibodies. (C) Subcellular localization of FLAG-IMP1 and Rev proteins. The
Rev-RFP DNA was transfected into HeLa cells together with the wild-type or mutated
FLAG-IMP1 DNA. Subcellular distribution of FLAG-IMP1 and the endogenous Crm1
proteins was detected by immunoﬂuorescence staining using anti-FLAG or anti-Crm1
antibodies. Fluorescent signals for FLAG-IMP1, Rev-RFP and Crm1 are pseudo-colored
as blue, red and green, respectively.
211Y. Zhou et al. / Virology 393 (2009) 210–220spliced HIV-1 RNA,which is attributed to the ability of IMP1 to interact
with Rev and to relocate Rev from the nucleus into the cytoplasm.
Results
IMP1 interacts with Rev protein and its ectopic expression causes
relocation of Rev from the nucleus to the cytoplasm
IMP1 shuttles between the nucleus and the cytoplasm as a
component of RNP complex and may thus have a potential role in
regulating nuclear export of RNA (Yisraeli, 2005). HIV-1 Rev is also a
shuttling protein and controls nuclear export of HIV-1 full-length and
singly spliced RNA (Pollard and Malim, 1998). We therefore asked
whether IMP1 and Rev happen to interact with each other when they
trafﬁc between the nucleus and the cytoplasm. To address this,
HEK293T cells were co-transfected with the FLAG-IMP1 and Rev DNA
constructs. The FLAG-IMP1 protein was then immunoprecipitated
from cell lysates using the anti-FLAG antibody. The results of Western
blotting showed that Rev protein was readily detected in precipitated
materials (Fig. 1A, B). Deletion of the four KH domains, but not the two
RRM domains or the KH3/KH4 domains, eliminated this interaction
(Fig. 1A, B). Association of IMP1 and Rev was next investigated by
imaging analysis to determine whether these two proteins co-localize
in cells. To this end, we transfected HeLa cells with Rev-RFP DNA alone
or together with the FLAG-IMP1 DNA. Rev-RFP was detected in the
nucleoli in cells that were transfected only by Rev-RFP DNA (Fig. 1C).
It is known that Rev binds to Crm1 and exports HIV-1 full-length RNA
into the cytoplasm via the Crm1 pathway (Pollard and Malim, 1998).
In the absence of Rev-RFP, Crm1 was evenly distributed within the
nucleoplasm with a modest accumulation along the nuclear rim
(Fig. 1C). Expression of Rev-RFP led to accumulation of Crm1 in the
nucleoli, suggesting that Rev sequesters a substantial amount of Crm1
protein within the nucleoli for its own use. When both Rev-RFP and
FLAG-IMP1 were expressed, a signiﬁcant amount of Rev-RFP was
detected within the cytoplasm and co-localized with FLAG-IMP1
(Fig. 1C). Expression of FLAG-ΔRRM(1–2), but not FLAG-ΔKH(1–4),
resulted in substantial relocation of Rev-RFP from the nucleus into the
cytoplasm (Fig. 1C). Interestingly, the FLAG-ΔKH(3–4) protein was
unable to change the subcellular location of Rev-RFP, although Rev
was efﬁciently co-immunoprecipitated with FLAG-ΔKH(3–4) (Fig. 1B,
C), indicating that interaction of FLAG-IMP1 with Rev is necessary but
insufﬁcient to divert Rev from the nucleus into the cytoplasm. Taken
together, these results suggest that IMP1 interacts with Rev and has
the ability of altering Rev subcellular distribution.
Ectopic expression of IMP1 suppresses Rev-dependent expression of the
CAT enzyme
Given the adverse effects of IMP1 on Rev subcellular localization,
we speculated that ectopic IMP1 expression impairs the function of
Rev. To test this, we utilized the pDM128 plasmid DNA that expresses
the CAT enzyme in a Rev-dependent manner (Hope et al., 1990).
Results of Fig. 2A show that cotransfection of FLAG-IMP1 DNA led to a
6-fold reduction of Rev-dependent CAT production. Further testing a
panel of IMP1 mutants revealed that the FLAG-ΔRRM(1–2) mutant
inhibited CAT expression by 2-fold as opposed to modestly stimulated
CAT expression by the FLAG-ΔKH(1–4) or FLAG-ΔKH(3–4) mutants
(Fig. 2B), which is in accordance with the effect of these mutants on
the subcellular location of Rev (Fig. 1C). Therefore, ectopic IMP1
expression inhibits the function of Rev and the KH domains play an
important role in this inhibition activity.
Since Rev-dependent gene expression requires speciﬁc access to
Crm1-mediated nuclear export pathway, we next tested whether
IMP1 adversely affects Rev-dependent CAT expression through
speciﬁcally impairing the function of Crm1 but not TAP. Toward this
end, a reporter construct named DM128-ms2×4was employed in thefollowing experiments. This DNA construct contains four copies of RNA
binding sites for the MS2 protein (Yi, Bogerd, and Cullen, 2002).
Through co-transfection with MS2-Crm1 or MS2-TAP DNA, Crm1 or
TAP protein is recruited to the DM128-ms2×4 mRNA as a result of
speciﬁc binding of MS2 to its RNA ligandms2, followed by the nuclear
export of DM128-ms2×4 mRNA and expression of CAT enzyme
(Fig. 3A).WhenFLAG-IMP1was expressed, theMS2-Crm1-dependent,
but not MS2-TAP-dependent, expression of CAT enzyme was signi-
ﬁcantly reduced (Fig. 3A). Results of further studies showed that the
KHdomainswere essential for this inhibitory activity of IMP1 (Fig. 3B).
This ﬁnding was conﬁrmed by the results of experiments performed
with the GPV-ms2×6 DNA construct that encode HIV-1 Gag and Gag-
Pol proteins and carries six copies of RNA binding sites for the MS2
protein. The results in Fig. 3C show that IMP1 expression speciﬁcally
inhibited Crm1-dependent, but not TAP-dependent, production of Gag
andGag-Pol proteins. Taken together, the data suggest that, in addition
Fig. 1 (continued).
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Rev-dependent gene expression by targeting the Crm1-mediated
nuclear export pathway.
Ectopic expression of IMP1 leads to signiﬁcant accumulation of multiple
spliced HIV-1 RNA
Rev protein promotes the nuclear export of the unspliced and
singly spliced HIV-1 RNA and thus represents a key viral factor in
maintaining the balance between the unspliced and spliced viral RNA
species (Pollard and Malim, 1998). The adverse effect of ectopic IMP1
on Rev function is expected to result in abnormal proﬁles of HIV-1
RNA expression. To test this, we transfected HEK293T cells with HIV-1
proviral DNA clone BH10 together with different amounts of FLAG-
IMP1 DNA and assessed expression of viral RNA by Northern blotting.
HIV-1 RNA of three different sizes were detected, and they represent
the 9-kb unspliced RNA, the 4-kb singly spliced RNA and the 2-kb
multiple spliced RNA (Fig. 4A). When 0.2 μg of FLAG-IMP1 DNA was
used for co-transfection, levels of both the 9-kb and 2-kb viral RNAwere increased with a much greater augmentation for the 2-kb
species (Fig. 4A). Increasing FLAG-IMP1 expression further elevated
the amount of 2 kb viral RNA as opposed to a gradual decline of 9 kb
viral RNA (Fig. 4A). These results indicate that ectopically expressed
FLAG-IMP1 causes accumulation of multiple spliced viral RNA.
We next tested three IMP1 mutants, including FLAG-ΔRRM(1–2),
FLAG-ΔKH(1–4), FLAG-ΔKH(3–4), to determine which region of
IMP1 plays the critical role in altering HIV-1 RNA expression. Each of
these DNA constructs was co-transfected with BH10 DNA into
HEK293T cells. The results of Northern blotting showed that the
FLAG-ΔRRM(1–2) protein, but not the FLAG-ΔKH(1–4) and FLAG-
ΔKH(3–4) proteins, caused signiﬁcant accumulation of the 2-kb viral
RNA (Fig. 4B), suggesting the indispensable role of the KH3 and KH4
domains for IMP1 to change HIV-1 RNA expression.
The KH3 and KH4 domains represent the key RNA-binding motifs
of IMP1 (Nielsen et al., 2004). Results of a recent study further show
that the KH4 domain directly contacts with the RNA target and that
expression of a KH4-deleted mutant named EGFP-IMP1-ΔKH4, but
not the wild-type EGFP-IMP1, affects cell migration (Oberman et al.,
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sequence in IMP1 modulating HIV-1 RNA expression. To this end, the
EGFP-IMP1 and EGFP-IMP1-ΔKH4 DNA constructs were used to
transfect HEK293T cells together with BH10 DNA. Similar to theresults obtained with FLAG-IMP1, expression of EGFP-IMP1 also
signiﬁcantly enhanced expression of the 2-kb HIV-1 RNA albeit
modestly inhibited production of the 9-kb RNA (Fig. 4C). In contrast,
expression of EGFP-IMP1-ΔKH4 did not affect levels of the unspliced
and spliced HIV-1 RNA (Fig. 4D). These results indicate the key role of
the KH4 domain of IMP1 in modulating HIV-1 RNA expression.
The EGFP-IMP1 fusion protein potently suppresses production of
infectious HIV-1 particles
While measuring the effect of EGFP-IMP1 or EGFP-IMP1-ΔKH4 on
HIV-1 RNA expression, we also monitored their effects on production
of Gag protein and HIV-1 particles by Western blotting and ELISA. In
contrast with the modest inhibition of Gag production in HEK293T
cells transfected by FLAG-IMP1 (Zhou et al., 2008), EGFP-IMP1
suppressed Gag expression by as much as 30-fold when 1 μg of
EGFP-IMP1 DNA was used in transfection (Fig. 5A, B). This profound
decrease of Gag expression accounts, to a large extent, for the 100-fold
inhibition of virus production (Fig. 5C). Furthermore, when viruses
equivalent to the same amount of HIV-1 p24 antigen were tested for
their infectivity by infecting TZM-bl indicator cells, the results showed
that EGFP-IMP1 diminished the infectivity of HIV-1 virions by asmuch
as 30-fold (Fig. 5D). In contrast, the EGFP-IMP1-ΔKH4 mutant
diminished Gag expression by 3-fold (Fig. 6A, B), reduced virus
production by 10-fold (Fig. 6C), and decreased infectivity of HIV-1
virions by 7-fold (Fig. 6D). Further increasing the amount of EGFP-
IMP1-ΔKH4 DNA to 2 μg in transfection did not inhibit HIV-1
production to a more severe extent (Fig. 6). It was noted that
expression of FLAG-IMP1 or EGFP-IMP1 protein did not affect the
viability of transfected cells within the period of experiments. These
results suggest that the EGFP moiety greatly enhances the potency of
IMP1 in suppressing production of infectious HIV-1 particles and that
the KH4 domain plays an important role in this event.
Ectopic expression of IMP1 and IMP2 inhibit replication of HIV-1 in
SupT1 cells
Wenext assessed the effect of IMP1 onHIV-1 replication in a CD4+
T-cell line named SupT1. To this end, a SupT1 cell linewas generated to
express FLAG-IMP1 with induction by a tetracycline derivative
doxycycline (Fig. 7A). As a control, a second SupT1 cell line was
engineered to express the FLAG-ΔKH(1–4) mutant whose expression
does not affect HIV-1 production (Zhou et al., 2008). Wild-type HIV-1
was used to infect the FLAG-IMP1 and FLAG-ΔKH(1–4) cell lines in the
absence or presence of doxycycline. The results showed that expres-
sion of FLAG-IMP1 reduced production of HIV-1, as opposed to a
modest increase of virus production with expression FLAG-ΔKH(1–4)
(Fig. 7B).We further tested the two homologues of IMP1, namely IMP2
and IMP3, in these experiments. The results showed that IMP2
inhibited HIV-1 replication in SupT1 cells to a more signiﬁcant extent
than IMP1, whereas IMP3 did not exert any effect on HIV-1 infection
(Fig. 7). Together, these data support the inhibitory role of IMP1 in
HIV-1 replication in CD4+ T cells and further indicate that IMP2
possesses a stronger inhibitory activity toward restricting HIV-1
infection. This explains why knockdown of IMP1 alone does not
signiﬁcantly affect HIV-1 production (Zhou et al., 2008).Fig. 2. Ectopic expression of FLAG-IMP1 inhibits Rev-dependent expression of CAT
enzyme. (A) Different amounts of FLAG-IMP1 DNAwere transfected into HEK293T cells
together with the pDM128 reporter DNA and Rev DNA. Levels of the CAT activity were
measured as being described in Materials and Methods. Result from one representative
experiment is shown. The average of three independent transfection experiments is
summarized in the bar graph with level of CAT activity in the control experiment (0 μg
of FLAG-IMP1 DNA) set as 100. (B) The pDM128 DNA, Rev DNA and the wild-type or
mutated FLAG-IMP1 DNAwere co-transfected into HEK293T cells. Levels of CAT activity
were measured as being described in Materials and Methods. Results from three
independent transfection experiments were summarized in the bar graph.
Fig. 3. FLAG-IMP1 inhibits Crm1-mediated but not TAP-mediated gene expression. (A) HEK293T cells were transfected by the DM128-ms2×4 DNA together with MS2-Crm1 or MS2-TAP in the presence of different amounts of FLAG-IMP1
DNA. (B) The DM128-ms2×4 and the MS2-Crm1 DNA was co-transfected with the wild-type or the mutated IMP1 DNA. Levels of CAT expression were measured as described in Materials and Methods. (C) The GPV-ms2×6 DNA was co-
transfected with either MS2-Crm1 or MS2-TAP in the presence of the wild-type IMP1 or its mutants. Levels of Gag expression in cells were assessed in Western blots using anti-HIV-1 p24 antibody. Expression of FLAG-IMP1 and its mutants











Fig. 4. Ectopic expression of FLAG-IMP1 leads to accumulation of multiple spliced HIV-1 RNA. (A) Northern blots to measure levels of the unspliced and spliced HIV-1 RNA in the
presence of ectopic expression of IMP1. HEK293T cells were transfected with BH10 DNA and different amounts of FLAG-IMP1 DNA. Total cellular RNAwas extracted and subjected to
Northern blotting using [α-32P] labeled HIV-1 DNA probes. The GAPDHmRNA was also detected as the internal control. RNA signals were measured using PhosphoImager. Ratios of
the multiple spliced vs. full-length viral RNA were calculated. Results shown are the average of two independent experiments. (B) The BH10 DNA was co-transfected with the wild-
type or themutated IMP1 DNA into HEK293T cells. Viral RNA expressionwas assessed by Northern blotting. The ratios of themultiple spliced and full-length viral RNA are presented.
Results shown are the average of two independent experiments. (C) Ectopic expression of EGFP-IMP1 causes accumulation of multiple spliced HIV-1 RNA. (D) Deletion of the KH4
domain alone abrogates the activity of IMP1 in affecting HIV-1 RNA expression.
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The full-length HIV-1 RNA undergoes complex alternative splicing,
which generates more than 30 different kinds of viral RNA (Frankel
and Young, 1998). On the basis of their splicing patterns and their
sizes, HIV-1 RNA can be divided into three major groups, the 9-kb
unspliced (full length) viral RNA, the 4-kb singly spliced (incomple-
tely spliced) viral RNA and the 2-kb multiple spliced (completely
spliced) viral RNA. At the early stage of HIV-1 gene expression, the
full-length viral RNA is spliced to produce the messenger RNA to
translate Tat, Rev and Nef proteins. Rev then shuttles back into the
nucleus and exports the unspliced and singly spliced viral RNA into
the cytoplasm to produce viral structural proteins such as Gag, Gag-
Pol and Env, which marks the late stage of viral gene expression andthe beginning of virus assembly. Rev plays a key role in regulating the
relative levels of different viral RNA species such that optimal
amounts of different viral proteins can be produced to ensure efﬁcient
virus production (Pollard and Malim, 1998). By exporting the
unspliced and singly spliced HIV-1 RNA into the cytoplasm, Rev
actually diminishes production of multiple spliced RNA including its
own messenger RNA. This feedback mechanism creates a balance
between unspliced and spliced viral RNA that relies on the level of Rev
and Rev's activity. Results of this study show that overexpression of
IMP1 changes the subcellular location of Rev and disturbs Rev's
function. A direct consequence of this interference is less efﬁcient
export of unspliced and singly spliced viral RNA that are therefore
further spliced to generate more multiple spliced viral RNA. A new
balance between different HIV-1 RNA species is reached when the
Fig. 5. EGFP-IMP1 impairs production of infectious HIV-1 particles. (A) Various amounts of EGFP-IMP1 DNA was transfected into HEK293T cells together with BH10 DNA (0.2 μg).
Expression of HIV-1 Gag protein and EGFP-IMP1 was examined by Western blotting using anti-p24(CA) and anti-EGFP antibodies, respectively. Levels of tubulin were also assessed
as the internal control. (B) Amounts of Gag and its derivatives (p40 and p24) in cells were determined by HIV-1 p24 ELISA. Results shown represent the average from three
independent transfection experiments. (C) Levels of HIV-1 particles in the culture supernatants were determined by HIV-1 p24 ELISA. Results shown represent the average from
three independent transfection experiments. (D) Infectivity of HIV-1 virions was measured by infecting the TZM-bl indicator cells using viruses equivalent to 10 ng of HIV-1 p24
antigen. Results shown represent three infection assays using viruses from three independent transfection experiments. RLU, relative luciferase unit. Values of the control
experiments performed with BH10 alone are arbitrarily set at 100. Percentages of Gag expression, virus yield and virus infectivity in the presence of EGFP-IMP1 expression are
calculated and indicated in the bar graphs.
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protein produced from the accumulated multiple spliced viral RNA.
This observation exempliﬁes how interfering with Rev function affects
the balance between the unspliced and spliced viral RNA and also how
the virus survives this disturbance by adjusting the levels of multiple
spliced viral RNA to produce more Rev and hereby restore efﬁcient
export of the unspliced viral RNA. As a result, expression of viral Gag
protein is not profoundly affected by overexpression of IMP1 (Zhou et
al., 2008). We also observed that expression of FLAG-IMP1 led to
modest increase in the levels of the full-length (9 kb) and singly
spliced (4 kb) viral RNA (Fig. 4A). One possible mechanism behind
this result is that IMP1 associates with HIV-1 RNA and increases viral
RNA stability. In support of this possibility, HIV-1 RNA is co-
immunoprecipitated with FLAG-IMP1 protein (unpublished data).
IMP1 is not the only cellular protein that has been reported to
affect subcellular distribution of Rev. Hax-1 has been shown to cause
relocation of Rev and inhibits Rev function (Modem and Reddy, 2008).
Rev's distribution in cells also changes under oxidative and osmotic
shocks but not with ultraviolet radiation and heat shock (Soros and
Cochrane, 2001). Inhibition of RNA transcription using actinomycin D
or dichlorobenzimidizole also leads to redistribution of Rev into the
cytoplasm (Meyer and Malim, 1994). These results further demon-
strate the shuttling nature of Rev in cells. In any case, the nucleolar
location is a prerequisite for Rev to function. For instance, mutation of
arginine residues in the arginine-rich domain leads to release of Rev
from the nucleolus and concomitant inhibition of Rev's RNA export
activity (Cochrane et al., 1990). Furthermore, randomly inserted
mutations that change the subcellular localization of Rev to thecytoplasm severely impede Rev function (Wolff et al., 2006). Given
that nucleoli undergo dynamic changes in response to extracellular
stimuli and nutrition conditions, the nucleolar localization may allow
Rev to sense these cues and regulate the rate of virus production
accordingly.
As opposed to the inhibitory role of IMP1 in HIV-1 Rev function, a
number of cellular factors have been shown to enhance Rev-mediated
expression of HIV-1 genomic RNA. One example is DDX3 that binds to
Crm1 and is essential for Rev/Crm1-mediated nuclear export of HIV-1
full-length RNA (Yedavalli et al., 2004). hRIP (human Rev-interacting
protein) is required for the release of HIV-1 RNA from the perinuclear
region (Sanchez-Velar et al., 2004). Sam68 (src-associated protein in
mitosis) is able to either promote nuclear export of HIV-1 RNA in a
Rev-independent manner or assist Rev to express RRE-containing
RNA (Li et al., 2002; Modem et al., 2005; Reddy et al., 1999; Soros et
al., 2001). It appears that the function of Rev is subject to a complex
regulation by a number of cellular factors.
The increased levels of multiple spliced HIV-1RNA may also be a
result of changed splicing efﬁciency at certain splice sites in HIV-1
RNA. There are four splice donor sites and eight splice acceptor sites in
HIV-1 RNA (Neumann et al., 1994; Purcell and Martin, 1993). The
splicing efﬁciency at each of these sites is modulated by the activities
of exonic splicing silencers (ESS) and intronic splicing silencers (ISS)
that are often bound by hnRNP A/B family or hnRNP H, as well as
exonic splicing enhancers (ESE) that are selectively bound by SR
proteins (Stoltzfus and Madsen, 2006). We currently cannot rule out
the possibility that IMP1 may recognize one of these ESS, ISS or ESE
elements and thus modulates splicing efﬁciency.
Fig. 6. Deletion of the KH4 domain alleviates the inhibitory effect of EGFP-IMP1 on production of infectious HIV-1 particles. (A) Western blots to measure expression of HIV-1 Gag
protein, EGFP-IMP1-ΔKH4 and tubulin. (B) Levels of Gag protein in cells were determined by HIV-1 p24 ELISA. (C) Levels of HIV-1 particles in culture supernatants were measured by
HIV-1 p24 ELISA. (D) HIV-1 infectivity was measured by infecting the TZM-bl indicator cells using viruses equivalent to 10 ng of HIV-1 p24 antigen. Data shown represent the results
from three independent experiments. RLU, relative luciferase unit. Percentages of Gag expression, virus yield and virus infectivity in the presence of EGFP-IMP1-ΔKH4 expression are
calculated and indicated in the bar graphs.
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reduce the production of infectiousHIV-1 particles by asmuch as 3000-
fold in comparison to the 25-fold inhibition by FLAG-IMP1 (Zhou et al.,
2008). This potent inhibition by EGFP-IMP1 reﬂects the sum of defects
in several steps of HIV-1 replication; these include a 30-fold decrease of
Gag expression in cells, a 100-fold diminution in virus production and a
30-fold reduction in the infectivity of HIV-1 virions. It is noted that
expression of FLAG-IMP1 protein only modestly reduced Gag expres-
sion in contrast with the potent inhibition effect from EGFP-IMP1
(Zhou et al., 2008). This may have resulted from the possibility that the
FLAG tag interferes with RNA-binding ability of IMP1, which is
supported by the results showing that the N-terminal glutathione S-
transferase (GST)-tagged or the N- and C-terminal His-tagged IMP1
binds to RNA with low afﬁnity (Nielsen et al., 1999). The EGFP tag
differs from the FLAG,GSTorHis tags in that EGFP is able tomultimerize
and may thus help IMP1 to form multimers (Jain et al., 2001). Since
several IMP1molecules bind to its RNA target in a cooperative manner
(Nielsen et al., 2004), the intrinsic multimerization property of EGFP
may have enhanced EGFP-IMP1 binding to RNA and consequently
increases the ability of IMP1 to modulate translation.
The KH4 domain is directly involved in IMP1 binding to RNA and is
essential for IMP1oligomerization (Nielsen et al., 2004;Obermanet al.,
2007). It is thus not surprising that deletion of KH4 sequence in the
context of EGFP-IMP1 largely alleviates suppression of Gag expression.
Interestingly, the EGFP-ΔKH4, EGFP-IMP1 and FLAG-IMP1 proteins all
reduced the efﬁciency of virus production by approximately 3-fold
following adjustment by the intracellular Gag levels. Therefore, as
opposed to its important role inmodulatingHIV-1 RNA expression, theKH4 domain is dispensable for IMP1 to interfere with the assembly of
HIV-1 particles.
In summary, results of this study reveal a new activity of IMP1 in
promoting expression of multiple spliced HIV-1 RNA by interfering
with the function of Rev protein. Importantly, attaching EGFP to IMP1
greatly enhances the activity of IMP1 to suppress production of
infectious HIV-1 particles, which raises the possibility of using EGFP-
IMP1 as a tool to develop new strategies to block HIV-1 infection.
Materials and Methods
Plasmid DNA and antibodies
The infectious HIV-1 proviral DNA clone BH10 was obtained from
the National Institutes of Health AIDS Research and Reference Reagent
Program. The pEGFP-IMP1 and pEGFP-IMP1-ΔKH4 DNA constructs
were kindly provided by Joel K .Yisraeli (Natkunam et al., 2007). They
express the EGFP-IMP1 fusion protein and the EGFP-IMP1-ΔKH4
mutant lacking the KH4 domain, respectively. The pFLAG-IMP1,
pFLAG-ΔRRM(1–2), pFLAG-ΔKH(1–4) and pFLAG-ΔKH(3–4) DNA
constructs were described previously (Zhou et al., 2008), they express
FLAG-tagged wild-type IMP1 and IMP1 mutants. The GPV-ms2×6
DNA construct was created by replacing the four copies of CTE
element within the GPV-CTEx4 DNA (Wodrich et al., 2000) with six
copies of the ms2-binding sites. The anti-GFP antibody was purchased
from Invitrogen, anti-FLAG and anti-tubulin antibodies from Sigma,
anti-HIV-1 p24 antibody from ID Labs, Inc., anti-Crm1 antibody from
Bethyl Laboratories.
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HEK293T, HeLa and TZM-bl cells were grown in Dulbecco's
modiﬁed Eagle's medium (DMEM) supplemented with 10% fetal
bovine serum (Invitrogen). The TZM-bl cells were obtained from the
National Institutes of Health AIDS Research and Reference Reagent
program (Wei et al., 2002). One day prior to transfection, HEK293TFig. 7. Effects of expression of IMP1, IMP2 and IMP3 on HIV-1 replication in SupT1 cells.
(A) Expression of FLAG-IMP1, FLAG-IMP2, FLAG-IMP3 and FLAG-ΔKH(1–4) in the
presence of doxycline. SupT1 cell lines were exposed to different amounts of doxycline
for 20 h before cells were harvested and lysed for Western blot analysis using
antibodies against FLAG or tubulin. (B) Growth of HIV-1 in SupT1 cells with the
expression of FLAG-IMP1, FLAG-IMP2, FLAG-IMP3 and FLAG-ΔKH(1–4). Each SupT1 cell
lines was infected with wild-type HIV-1 in the absence or presence of doxycycline (500
ng/ml). Levels of viral reverse transcriptase activity in the culture supernatants were
measured at different time points after infection. Results shown are the average of two
independent infection experiments.cells were seeded in six-well plate at 5×105 per well. Transfection
was performed with Lipofectamine 2000 (Invitrogen) in accordance
with the manufacturer's instruction.
Creating doxcycline-inducible SupT1 cell lines that express IMP1, IMP2
or IMP3 protein
The cDNA sequences of IMP1, IMP2 and IMP3, with the FLAG
sequence attached to the 5′ end, were cloned into a doxycycline-
inducible retroviral vector PUR-GOI (Clontech). The FLAG-ΔKH(1–4)
cDNA was also inserted into PUR-GOI. The created DNA clones were
co-transfected together with the VSV (vesicular stomatitis virus)-G
DNA into the GP2-293 packaging cell line to produce retrovirus
particles, which were used to infect SupT1 cells together with
viruses that express the rtTA activitor. One day after infection, G418
(1 mg/ml) and puromycin (2 μg/ml) were added into the culture to
select for stably infected cells. Expression of FLAG-IMP1, FLAG-IMP2,
FLAG-IMP2 and FLAG-ΔKH(1–4) in the presence of doxycycline was
assessed by Western blot using anti-FLAG antibody. Wild-type HIV-1
equivalent to 10 ng p24 antigen was used to infect 1×106 cells.
Growth of viruses was monitored by measuring the level of viral
reverse transcriptase activity in the culture supernatants.
HIV-1 protein analysis
HIV-1 proteins were detected either by Western blotting or by
HIV-1 p24 ELISA. HEK293T cells that have been transfected with the
BH10 DNA were harvested and lysed in the protein extraction buffer
(Novus Biologicals). Cell lysates of 20 μg proteins were fractionated on
SDS-10% PAGE followed by transfer of proteins onto polyvinylidene
diﬂuoride membranes (GE Healthcare). After blocking with 5% milk
(in 1×phosphate buffered saline), the membranes were incubated
with anti-HIV-1 p24 antibodies (1:1000) for 2 h at room temperature,
followed by washing for three times with 1×phosphate buffered
saline containing 0.05% Tween 20. The membranes were then
incubated with the horseradish peroxidase conjugated secondary
antibodies for 1 h at room temperature. After washing with
1×phosphate buffered saline (0.05% Tween 20), the membranes
were treatedwith the ECL reagents (Perkin-Elmer) and exposed to the
X-ray ﬁlms to visualize the protein signals. The amounts of HIV-1 p24
antigen in the cell lysates or the culture supernatants were also
measured using the HIV-1 p24 microELISA kit (bioMerieux) following
instruction from the manufacturer.
HIV-1 RNA analysis
Levels of HIV-1 RNA in HEK293T cells that had been transfected by
the BH10 DNAwere measured by denaturing Northern blotting (Zhou
et al., 2008). Brieﬂy, total cellular RNA was extracted using Trizol
reagent (Invitrogen) followed by electrophoresis in 1% denaturing
agarose gels in a 1×MOPS (3-(N-morpholino) propanesulfornic acid)
buffer at 100 V for 4 h. RNA was then transferred to hybond N
membranes and hybridized to [α-32P]-labeled HIV-1 DNA probes
(HIV-1 nucleotide positions 1–2000 in BH10). RNA signals were
visualized by exposure to X-ray ﬁlms. Intensity of the signals was
measured using a PhosphoImager (Storm 840, Amersham).
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TZM-bl cells were seeded in 24-well plates at 4×104 cells per well
1 day prior to infectionwith HIV-1 virions equivalent to 10 ng of HIV-1
p24 antigen. The infected cells were collected 40 h later and lysed in
100 μl of 1×passive lysis buffer (Promega). The lysates (10 μl) were
mixed with 100 μl of ﬁreﬂy luciferase substrate solution (Promega)
followed by reading luciferase activity in an luminometer (Promega).
CAT (chloramphenicol acetyl transferase) assay
HEK293T cellswere seeded in six-well plates at 5×105 cells perwell
1 day before transfection with 100 ng pDM128 and 50 ng pRev DNA.
The TK-RL DNA (100 ng) was also used in transfection. Expression of
Renilla luciferase was measured using luciferase assay kit (Promega)
and the data were used as an internal control to normalize the levels of
CAT activity. pDM128 carries the CAT gene and the Rev response
element (RRE) and expresses CAT enzyme in a Rev-dependentmanner
(Hope et al., 1990). Cellswere harvested and suspended in 200 μl of 250
mM Tris–HCl (pH 7.5). After three times of freeze and thaw, cells were
pelleted at 1000×g at 4 °C for 10 min to remove the nuclei and cell
debris. 10 μl of the cell lysates were mixed with a reaction buffer
containing 250 mM Tris–HCl (pH 7.5), 0.3 mg/ml n-butyryl coenzyme
A (Sigma), 30 μM[14C]chloramphenicol (at 50 μCi/ml, Amersham), and
incubated at 37 °C for 1 h. The substrates and the products were
extracted with ethyl acetate, spotted on to the TLC plate and separated
by chromatography using chlorophorm/methanol (190:10, v/v).
[14C]chloramphenicol and the products were visualized by exposure
to X-ray ﬁlms and their levels were quantiﬁed using a PhosphorImager
(Storm 840; Amersham).
Immunomicroscopy
HeLa cells were seeded in a four-well chamber slide (40,000 cells
per well) and transfected with the pRev-RFP (50 ng) and pFLAG-IMP1
(50 ng) DNA constructs. Cells were ﬁxed with 4% paraformaldehyde
(in 1×phosphate buffered saline) for 10 min at room temperature
followed by permeabilization with 0.2% Triton X-100 for 10 min. After
washing with 1×phospate buffered saline, cells were incubated with
mouse anti-FLAG (1:500) and anti-Crm1 (1:200) antibodies for 2 h at
room temperature, followed by incubation with Alexa Fluor 488-
conjugated anti-mouse and Alexa Fluor 546-conjugated anti-rabbit
secondary antibodies (Molecular Probes). Images were recorded
using the PASCAL laser scanning confocal microscope (Zeiss).
Immunoprecipitation
HEK293T cells were transfected with the FLAG-IMP1 DNA and the
pRev DNA. Cells were lysed in a buffer containing 50mMTris–HCl (pH
7.4), 150 mM NaCl, 1 mM EDTA, 1% Triton X-100 and protease
inhibitor cocktail (Roche). Following clariﬁcation by spinning at
10,000×g for 10 min at 4 °C, cell lysates of 1 mg were incubated with
30 μl slurry of agarose beads coated with anti-FLAG antibody (Sigma)
for 2 h at 4 °C. After washing with a buffer containing 50 mM Tris–HCl
(pH 7.4), 150 mM NaCl and protease inhibitor cocktail (Roche), the
beads were incubated with 150 ng/μl 3×FLAG peptides (Sigma) for
30min to elute the FLAG-IMP1 and the associated proteins. The eluted
materials were assessed by Western blotting using anti-FLAG or anti-
Rev antibodies.
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